<DOC>
	<DOCNO>NCT02639702</DOCNO>
	<brief_summary>Plasma half-life routinely use establish dose schedule antipsychotic ; example , recommend agent short plasma half-life administer multiple time per day . However , date , several randomize control trial ( RCTs ) show difference clinical outcome once- twice-daily dose various antipsychotic , suggest once-daily dosing antipsychotic viable option regardless plasma half-life . This would apply clozapine well ; however , study compare once-daily vs. twice-daily dosing regimen clozapine term efficacy tolerability . To address gap literature , investigator shall conduct pilot , double-blind , RCT examine efficacy tolerability follow switch once-daily dose regimen clozapine patient schizophrenia receive clozapine twice day .</brief_summary>
	<brief_title>Switching From Twice-Daily Once-Daily Clozapine Dosing Schizophrenia</brief_title>
	<detailed_description>Plasma half-life routinely use establish dose schedule antipsychotic ; example , recommend agent short plasma half-life administer multiple time per day . To date , however , several randomize control trial ( RCTs ) show once-daily dose antipsychotic include perphenazine , risperidone , olanzapine , quetiapine , asenapine comparable twice-daily dosing term efficacy tolerability , suggest once-daily dosing antipsychotic viable option regardless plasma half-life . This issue apply clozapine well , relatively short plasma half-life 12-16 hour ; note , product monograph recommend clozapine administer daily dose exceeds 200 mg/day Canada . Despite , clinical practice clozapine frequently administer daily convenience side effect daytime sedation somnolence , In support , cross-sectional survey do investigator ' centre reveal clozapine prescribe daily 75.1 % 676 patient , even though &gt; 200 mg/day administer 88.6 % . However , study compare once-daily vs. twice-daily dosing regimen clozapine term efficacy tolerability . To address gap literature , investigator shall conduct pilot , double-blind , RCT examine efficacy tolerability follow switch once-daily dose regimen clozapine patient schizophrenia receive clozapine twice day .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<criteria>Diagnosed schizophrenia schizoaffective disorder base DSMIV criterion Outpatient status Ages 18 year old Has receive clozapine twice day , one evening/bedtime , dose dose regimen least 3 month Fluent English competent provide write inform consent Having significant medical neurological illness Pregnant lactating</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Clozapine</keyword>
	<keyword>Dosing</keyword>
	<keyword>Once daily</keyword>
	<keyword>Regimen</keyword>
	<keyword>Schizophrenia</keyword>
</DOC>